Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
Phase 4
1,000
about 5 years
40–62
Female only
5 sites in MA, MI, NC +2
About this study
Researchers are testing whether digital therapy, trazodone, or daridorexant are more effective than each other at treating insomnia in women going through menopause. The trial will also look at the safety of these treatments. Participants will use one of three methods to treat their insomnia for 12 months and provide information about their sleep and health.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Cognitive behavioral therapy for insomnia (CBT-i)
- 2.Take Daridorexant
- 3.Take Trazodone
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
daridorexant, trazodone
oral (Oral Tablet)
Primary: PROMIS Sleep Disturbance T-score
Secondary: Insomnia Severity Index, Menopause-related Quality of Life, Occurrences of events of special interest and/or adverse events, PROMIS Anger Scale, PROMIS Anxiety Scale, PROMIS Cognitive Function Abilities Scale, PROMIS Depression Scale, PROMIS Fatigue Score
therapy